Valvular Heart Disease in the Elderly

被引：1

作者：

Cawley P.J. ^{[1
]}

Otto C.M. ^{[1
]}

机构：

[1] Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, 98195-6422

来源：

Current Cardiovascular Risk Reports | 2011年 / 5卷 / 5期

关键词：

Aortic stenosis; Elderly; Mitral regurgitation; Valve disease; Valvular heart disease;

D O I：

10.1007/s12170-011-0187-z

中图分类号：

学科分类号：

摘要：

Clinicians are increasingly caring for elderly patients with valvular heart disease due in part to an aging population and a decline in rheumatic heart disease. Aortic stenosis (AS) and mitral regurgitation (MR) are the most common valve lesions encountered. Calcific AS represents a disease spectrum from aortic sclerosis to severe, symptomatic AS; the latter of which has a significantly limited prognosis. Surgical aortic valve replacement is the recommended therapy and can improve life expectancy. Although increased age is associated with a slight increase in surgical risk, co-morbidities are primarily associated with increased surgical risk. If approved, transcatheter aortic valve implantation may be an option in some patient subsets pending the results of multi-center randomized controlled trials. MR in the elderly population may be associated with primary left ventricular dysfunction (functional MR) or primary MR (leaflet disease). Both are associated with heart failure and can result in increased morbidity. Therapy for functional MR is aimed at the medical treatment for heart failure. Therapy for primary MR is aimed at surgery if accepted indications exist. © 2011 Springer Science+Business Media, LLC.

引用

页码：413 / 421

页数：8

共 43 条

[1]

Roberts W.C., Ko J.M., Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation, Circulation, 111, 7, pp. 920-925, (2005)

[2]

Lindroos M., Kupari M., Heikkila J., Tilvis R., Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample, J Am Coll Cardiol, 21, 5, pp. 1220-1225, (1993)

[3]

Stewart B.F., Siscovick D., Lind B.K., Et al., Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study, J Am Coll Cardiol, 29, 3, pp. 630-634, (1997)

[4]

Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., Siscovick D.S., Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly, N Engl J Med, 341, 3, pp. 142-147, (1999)

[5]

Stritzke J., Linsel-Nitschke P., Markus M.R., Et al., Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey, Eur Heart J, 30, 16, pp. 2044-2053, (2009)

[6]

Katz R., Wong N.D., Kronmal R., Et al., Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis, Circulation, 113, 17, pp. 2113-2119, (2006)

[7]

Novaro G.M., Katz R., Aviles R.J., Et al., Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study, J Am Coll Cardiol, 50, 20, pp. 1992-1998, (2007)

[8]

O'Brien K.D., Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more), Arterioscler Thromb Vasc Biol, 26, 8, pp. 1721-1728, (2006)

[9]

Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D., Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies, Circulation, 90, 2, pp. 844-853, (1994)

[10]

Freeman R.V., Otto C.M., Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies, Circulation, 111, 24, pp. 3316-3326, (2005)

← 1 2 3 4 5 →